Steve Miller, Chief Operating Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 100,000 shares at $15.28 ($1.6M) on 2022-11-21, disclosed to the SEC on 2022-11-23.
Open-market sale of $1.6M CPRX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.28 | 80,000 | $1.2M | 77.9% |
| 2 | $17.34 | 20,000 | $347K | 22.1% |
| Total | $15.69 avg | 100,000 | $1.6M | 100% |
| Filing → |
| CPRX | SELL | 2024-08-22 | $4.1M | — | Filing → |
| CPRX | SELL | 2023-12-07 | $570K | — | Filing → |
| CPRX | SELL | 2022-09-15 | $2.4M | — | Filing → |